EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study

Hiroki Masuda iD, Akiyuki Uzawa iD, Mamoru Shibata iD, Masahiro Mori, Yusei Miyazaki iD, Masaaki Niino, Juichi Fujimori, Ichiro Nakashima iD, Yoshiki Takai, Naoya Yamazaki iD, Tatsuro Misu, Makoto Kinoshita und 30 weitere

Cephalalgia · 2026-03 · 46 (3)

DOI: 10.1177/03331024261429158 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cephalalgia, online erschienen am 26.03.2026. Verfasst von Hiroki Masuda und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Headache, Multiple Sclerosis, Myasthenia Gravis, Migraine Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Several studies have reported a higher prevalence of migraine in patients with multiple sclerosis (MS) than in healthy controls (HCs). The aim of this study was to elucidate the headache prevalence in patients with MS or other neuroimmunological disorders, as well as to investigate the associations between headache characteristics and disease activity.

Methods

In this multicenter study in Japan, a headache questionnaire was distributed to patients with MS (n = 338), aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder (NMOSD; n = 106), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD; n = 51) or acetylcholine receptor antibody-positive myasthenia gravis (MG; n = 104), and healthy controls (HCs; n = 407). We included only participants aged 18–65 years in this study. The questionnaire responses were classified according to the International Classification of Headache Disorders, 3rd edition. The questionnaire was designed to systematically capture headache characteristics based on established diagnostic criteria.

Results

In total, any type of headache was found for 54.1% in MS, 63.2% in NMOSD, 43.1% in MOGAD, 43.3% in MG and 43.5% in HCs. After Holm–Bonferroni correction for comparisons among the five groups, the MS ( p = 0.015) and NMOSD ( p < 0.001) groups had significantly higher odds of any headache compared to the HC group. No difference was observed for migraine (MS 16.0%, NMOSD 16.0%, MOGAD 9.8%, MG 12.5%, HCs 17.0%). In contrast, patients with MS (24.0%) and NMOSD (37.7%) showed a significantly higher frequency of tension-type headache (TTH) than HCs (16.7%) even after adjusting for age and sex. Neither disease activity nor disease-modifying therapy displayed any association with headache severity in patients with MS, NMOSD, or MOGAD.

Conclusions

Our study showed no increased prevalence of migraine in MS and other neuroimmunological disorders, whereas TTH comorbidity was higher in MS and NMOSD than in controls.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeadacheMultiple SclerosisMyasthenia GravisMigraine DisordersAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultJapanMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseNeuromyelitis OpticaPrevalenceSurveys and Questionnaires

Stichwörter der Autor:innen

comorbiditymigrainemultiple sclerosisneuromyelitis optica spectrum disordertension-type headache

Autor:innen und Institutionen

  • Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Department of Neurology, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan.
  • Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan.
  • Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.
  • Department of Neurology, Tohoku University Hospital, Sendai, Japan.
  • Department of Neurology, Graduate School of Medicine, The University of Osaka, Suita, Japan.

ORCID-Profile: Hiroki Masuda, Akiyuki Uzawa, Mamoru Shibata, Yusei Miyazaki, Ichiro Nakashima, Naoya Yamazaki, Koji Sekiguchi, Hajime Takeuchi, Keisuke Mizutani, Ayano Matsuyoshi, Noriko Isobe, Sonoko Misawa, Tomoki Suichi, Manato Yasuda, Hideo Handa, Etsuko Ogaya, Satoshi Kuwabara

Zitieren

APA

Masuda, H., Uzawa, A., Shibata, M., Mori, M., Miyazaki, Y., Niino, M., Fujimori, J., Nakashima, I., Takai, Y., Yamazaki, N., Misu, T., Kinoshita, M., Okuno, T., Sekiguchi, K., Nakahara, J., Takeuchi, H., Mizutani, K., Matsuyoshi, A., Kira, Y. I., …, & Kuwabara, S. (2026). Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study. Cephalalgia, 46(3). https://doi.org/10.1177/03331024261429158

Vancouver

Masuda H, Uzawa A, Shibata M, Mori M, Miyazaki Y, Niino M, et al. Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study. Cephalalgia. 2026;46(3). doi:10.1177/03331024261429158

BibTeX
@article{Masuda2026,
  author = {Masuda, Hiroki and Uzawa, Akiyuki and Shibata, Mamoru and Mori, Masahiro and Miyazaki, Yusei and Niino, Masaaki and Fujimori, Juichi and Nakashima, Ichiro and Takai, Yoshiki and Yamazaki, Naoya and Misu, Tatsuro and Kinoshita, Makoto and Okuno, Tatsusada and Sekiguchi, Koji and Nakahara, Jin and Takeuchi, Hajime and Mizutani, Keisuke and Matsuyoshi, Ayano and Kira, Yuu-Ichi and Iwao, Kazunori and Tanaka, Eizo and Shinoda, Koji and Watanabe, Mitsuru and Masaki, Katsuhisa and Isobe, Noriko and Muto, Mayumi and Ohtani, Ryohei and Aoyama, Shinji and Misawa, Sonoko and Shibuya, Kazumoto and Suichi, Tomoki and Yasuda, Manato and Aotsuka, Yuya and Morooka, Marie and Otani, Ryo and Onishi, Yosuke and Akamine, Hiroyuki and Handa, Hideo and Ogaya, Etsuko and Ogushi, Moeko and Kurumada, Kentaro and Kuwabara, Satoshi},
  title = {Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study},
  journal = {Cephalalgia},
  year = {2026},
  volume = {46},
  number = {3},
  doi = {10.1177/03331024261429158}
}
Kostenlos starten →